Request Sample
Request Methodology
Description
Endobronchial Ultrasound (EBUS) Devices Market size is expected to be USD x million in 2021, growing at a high CAGR of 4.6% from 2022 to 2028 to reach USD x million by 2028. Endobronchial Ultrasound (EBUS) Devices Market has emerged as a routinely performed procedure in diagnostic bronchoscopy. It is a minimally invasive procedure. It is a combination of bronchoscopy and ultrasound. It is used for the evaluation of tumor involvement of the tracheobronchial wall and mediastinum and plays an essential role as a guidance technique for peripheral pulmonary disease. EBUS plays a vital role in the minimally invasive staging of nonsmall cell lung cancer. The role of EBUS is progressively expanding to include peribronchial lesions, pulmonary nodules, and other mediastinal abnormalities. Recently, EBUS has assisted in the diagnosis of many other disease entities, including malignancies and various infections like TB and sarcoidosis. It is significantly cost effectively when compared to standard techniques. In 2016, American Association created 3 new CPT codes for EBUS. Players are also focussing on various growth strategies such as new product launches and development, acquisitions, collaborations, and partnerships to enhance their market presence in the global EBUS devices market. For Instance, in May 18, 2017, Olympus launched its new ViziShot 2 single-use aspiration needles and expanded the EBUS Transbronchial Needle Aspiration device portfolio. In 2014, Cook Medical introduced EchoTip ProCore the first EBUS needle in the U.S. and Europe that can acquire histological samples. The market is growing due to an increase in demand for minimally invasive medical procedures and widespread adoption of the procedure by interventional radiologists and diagnostic departments to diagnose diseases for healthcare institutions such as medical clinics and diagnostic centers, among others. The market is also influenced by people’s growing knowledge of early diagnosis and its benefits, as well as the widespread use of biopsy to diagnose cancer and identify healthy cells or calluses from tumorous cells.
